SCHEMBL6675253

SCHEMBL6675253

Fc1ccc(Nc2nc(Cl)ncc2Br)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
CDK1 P06493 2/20 0.50
IGF1R P08069 3/20 0.47
AURKA O14965 1/20 0.47
TXN P10599 1/20 0.45
GSK3B P49841 1/20 0.42
PIN1 Q13526 2/20 0.41
KDR P35968 2/20 0.41
EGFR P00533 1/20 0.41
HTR2C P28335 2/20 0.40
ABL1 P00519 1/20 0.40
BCR P11274 1/20 0.40
CTSC P53634 1/20 0.40
HTR2A P28223 1/20 0.40
STK17B O94768 2/20 0.39
STK17A Q9UEE5 2/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6211352 0.84 MEN1 (0.66) MEN1KMT2ACDK1IGF1RAURKA
SCHEMBL6923416 0.83 CTSC (0.53) MEN1KMT2AAURKATXNPIN1
SCHEMBL1774193 0.83 IGF1R (0.68) MEN1KMT2ACDK1IGF1RGSK3B
SCHEMBL15584950 0.81 AURKA (0.47) MEN1KMT2AAURKATXNPIN1
SCHEMBL16685087 0.81 AURKA (0.47) MEN1KMT2AAURKATXNPIN1
SCHEMBL15146279 0.81 AURKA (0.47) MEN1KMT2AAURKATXNPIN1
SCHEMBL22719010 0.80 MEN1 (0.61) MEN1KMT2AIGF1RAURKA
SCHEMBL29535612 0.80 MEN1 (0.61) MEN1KMT2AIGF1RAURKA
SCHEMBL30749092 0.78 MEN1 (0.55) MEN1KMT2ACDK1IGF1RGSK3B
SCHEMBL16684757 0.77 CYP1A2 (0.50) MEN1KMT2AAURKATXNKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004046118-A2 2-4-(DI-PHENYL-AMINO)-PYRIMIDINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-03 WO disclosed
WO-2004039359-A2 USE OF PYRIMIDINE DERIVATES FOR THE MANIFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-05-13 WO disclosed
WO-2003095448-A1 PYRIDINYL AMINO PYRIMIDINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2003-11-20 WO disclosed